Consistent with a previous report in colorectal cancer lines [35], we observed a marked increase in phosphorylated STAT3 after MEK1/2 inhibition in breast cancer lines, suggesting an acute rewiring of compensatory pathway upon MEK1/2 inhibition (Fig. 1c). Here, MAP2K1 is linked to breast cancer.